+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America HPV Testing and Pap Test Market By Type, By Application, By Product, By End Use, By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

  • ID: 5354465
  • Report
  • June 2021
  • Region: North America
  • 84 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Abbott Laboratories
  • Arbor Vita Corporation
  • F. Hoffmann-La Roche Ltd.
  • Femasys, Inc.
  • Hologic, Inc.
  • Qiagen N.V.`
  • MORE
The North America HPV Testing and Pap Test Market is expected to witness market growth of 32.6% CAGR during the forecast period (2021-2027).

HPV tests are DNA-based and allow the identification of particular strains of the virus in the specimen. HPV tests if done during the initial screening assist in the identification of abnormal cells that could become cancerous. This could prove beneficial in early detection and consequent prevention of disease, enabling healthcare experts to choose different treatment and/or preventive alternatives.

The growth of the regional market is further fueled by the high affordability, adoption rate, and access to advanced technological products and solutions. In addition to it, the existence of key market players and ongoing strategic initiatives undertaken by them has majorly supplemented the growth of the regional market. For example, Abbott Laboratories; Quest Diagnostics; Becton, Dickinson, and Company; Hologic, Inc. Femasys, Inc.; Arbor Vita Corporation are a few of the leading players operating in the HPV and Pap test market having their headquarters in the U.S.

As per the American Cancer Society, there was 13,170 new cases of invasive cervical cancer were diagnosed and there was a death of around 4,250 women from cervical cancer in the United States in 2019. Therefore, the growing number of cervical cancer cases may surge the demand for HPV testing and PAP tests, boosting the market growth. The increasing number of cervical cancer cases has fueled the demand for screening programs. These tests are proved to be beneficial in overcoming the limitations of conventional cervical screening that have resulted in alternative screening paradigms like those including detection of the human papillomavirus. Thus, the growing cases of cervical cancer across the North American region are expected to boost the demand for HPV testing and Pap test market over the forthcoming years.

The US market dominated the North America HPV Testing Market by Country 2020, thereby, achieving a market value of $844.5 million by 2027. The Canada market is experiencing a CAGR of 37.6% during (2021 - 2027). Additionally, The Mexico market is expected to witness a CAGR of 36.5% during (2021 - 2027).

Based on Type, the market is segmented into Pap Test and HPV Testing. Based on Application, the market is segmented into Cervical Cancer Screening, and Vaginal Cancer Screening. Based on Product, the market is segmented into Consumables, Instruments, and Services. Based on End Use, the market is segmented into Hospitals & Clinics, Laboratories and Other End Users. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Hologic, Inc., Quest Diagnostics, Incorporated, Seegene, Inc., Arbor Vita Corporation, Femasys, Inc., and Qiagen N.V.

Scope of the Study

Market Segments covered in the Report:

By Type
  • Pap Test
  • HPV Testing
By Application
  • Cervical Cancer Screening,
  • Vaginal Cancer Screening
By Product
  • Consumables
  • Instruments,
  • Services
By End Use
  • Hospitals & Clinics
  • Laboratories
  • Other End Users
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Quest Diagnostics, Incorporated
  • Seegene, Inc.
  • Arbor Vita Corporation
  • Femasys, Inc.
  • Qiagen N.V.
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Arbor Vita Corporation
  • F. Hoffmann-La Roche Ltd.
  • Femasys, Inc.
  • Hologic, Inc.
  • Qiagen N.V.`
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America HPV Testing And PAP Test Market, by Type
1.4.2 North America HPV Testing And PAP Test Market, by Application
1.4.3 North America HPV Testing And PAP Test Market, by Product
1.4.4 North America HPV Testing And PAP Test Market, by End Use
1.4.5 North America HPV Testing And PAP Test Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition & Scenario:
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
2.2.3 Market Opportunity

Chapter 3. North America HPV Testing And Pap Test Market by Type
3.1 North America Pap Test Market by Country
3.2 North America HPV Testing Market by Country

Chapter 4. North America HPV Testing And Pap Test Market by Application
4.1 North America Cervical Cancer Screening Market by Country
4.2 North America Vaginal Cancer Screening Market by Country

Chapter 5. North America HPV Testing And Pap Test Market by Product
5.1 North America Consumables Market by Country
5.2 North America Instruments Market by Country
5.3 North America Services Market by Country

Chapter 6. North America HPV Testing And Pap Test Market by Application
6.1 North America PCR Market by Country
6.2 North America Immunodiagnostics Market by Country
6.3 North America Other Technologies Market by Country

Chapter 7. North America HPV Testing And Pap Test Market by End Use
7.1 North America Hospitals & Clinics Market by Country
7.2 North America Laboratories Market by Country
7.3 North America Other End Uses Market by Country

Chapter 8. North America HPV Testing And Pap Test Market by Country
8.1 US HPV Testing And Pap Test Market
8.1.1 US HPV Testing And Pap Test Market by Type
8.1.2 US HPV Testing And Pap Test Market by Application
8.1.3 US HPV Testing And Pap Test Market by Product
8.1.4 US HPV Testing And Pap Test Market by Technology
8.1.5 US HPV Testing And Pap Test Market by End Use
8.2 Canada HPV Testing And Pap Test Market
8.2.1 Canada HPV Testing And Pap Test Market by Type
8.2.2 Canada HPV Testing And Pap Test Market by Application
8.2.3 Canada HPV Testing And Pap Test Market by Product
8.2.4 Canada HPV Testing And Pap Test Market by Technology
8.2.5 Canada HPV Testing And Pap Test Market by End Use
8.3 Mexico HPV Testing And Pap Test Market
8.3.1 Mexico HPV Testing And Pap Test Market by Type
8.3.2 Mexico HPV Testing And Pap Test Market by Application
8.3.3 Mexico HPV Testing And Pap Test Market by Product
8.3.4 Mexico HPV Testing And Pap Test Market by Technology
8.3.5 Mexico HPV Testing And Pap Test Market by End Use
8.4 Rest of North America HPV Testing And Pap Test Market
8.4.1 Rest of North America HPV Testing And Pap Test Market by Type
8.4.2 Rest of North America HPV Testing And Pap Test Market by Application
8.4.3 Rest of North America HPV Testing And Pap Test Market by Product
8.4.4 Rest of North America HPV Testing And Pap Test Market by Technology
8.4.5 Rest of North America HPV Testing And Pap Test Market by End Use

Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Approvals & Trials:
9.2.5.2 Product Launches and Product Expansions:
9.3 Thermo Fisher Scientific, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Becton, Dickinson and Company
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Approvals & Trials:
9.5 Hologic, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Approvals & Trials:
9.6 Quest Diagnostics, Incorporated
9.6.1 Company Overview
9.6.2 Financial Analysis
9.7 Qiagen N.V.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expense
9.8 Seegene, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Research & Development Expense
9.9 Arbor Vita Corporation
9.9.1 Company Overview
9.10. Femasys, Inc.
9.10.1 Company Overview
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Quest Diagnostics, Incorporated
  • Seegene, Inc.
  • Arbor Vita Corporation
  • Femasys, Inc.
  • Qiagen N.V.`
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll